azelastine hydrochloride

azelastine hydrochloride (DYMISTA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: ophthalmic. Current US regulatory status: approved.

DYMISTA is a marketed brand name for azelastine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

azelastine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.